Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care

Overview

Journal J Acquir Immune Defic Syndr

Specialty Infectious Diseases

Date 2017 Sep 9

PMID 28885271

Citations 6

Authors

Khai Hoan Tram

Florence Mwangwa

Mucunguzi Atukunda

Asiphas Owaraganise

James Ayieko

Albert Plenty

Dalsone Kwariisima

Tamara D Clark

Maya L Petersen

Edwin D Charlebois

Moses R Kamya

Gabriel Chamie

Diane V Havlir

Carina Marquez

Affiliations

Soon will be listed here.

Citing Articles

Differentiated HIV Service Delivery vs Conventional Care: Tuberculosis Preventive Therapy Outcomes for People Living with HIV in Sub-Saharan Africa.

Johnson A, Chimoyi L, Charalambous S, Kawaza N, Hoffmann C, Davis J medRxiv. 2025; .

PMID: 39867372 PMC: 11759609. DOI: 10.1101/2025.01.15.25320590.

Low completion rate for the 6-months course of isoniazid preventive therapy among people living with HIV, North Eastern Uganda, 2015-2017.

Eurien D, Okethwangu D, Aliddeki D, Kisaakye E, Nguna J, Bulage L Pan Afr Med J. 2024; 48:122.

PMID: 39525548 PMC: 11549237. DOI: 10.11604/pamj.2024.48.122.36745.

Isoniazid preventive therapy completion and factors associated with non-completion among patients on antiretroviral therapy at Kisenyi Health Centre IV, Kampala, Uganda.

Amanya I, Muhoozi M, Aruhomukama D, Ssebagereka A, Mugambe R PLoS One. 2023; 18(8):e0277739.

PMID: 37607176 PMC: 10443854. DOI: 10.1371/journal.pone.0277739.

Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries.

Jo Y, Gomes I, Flack J, Salazar-Austin N, Churchyard G, Chaisson R EClinicalMedicine. 2021; 31:100707.

PMID: 33554088 PMC: 7846666. DOI: 10.1016/j.eclinm.2020.100707.

A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.

Sensalire S, Karamagi Nkolo E, Nabwire J, Lawino A, Kiragga D, Muhire M AIDS Res Ther. 2020; 17(1):28.

PMID: 32460788 PMC: 7254658. DOI: 10.1186/s12981-020-00285-0.

References

Saito S, Mpofu P, Carter E, Diero L, Wools-Kaloustian K, Yiannoutsos C . Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012. J Acquir Immune Defic Syndr. 2016; 71(4):e96-e106. PMC: 5902407. DOI: 10.1097/QAI.0000000000000896. View

Bucher H, Griffith L, Guyatt G, Sudre P, Naef M, Sendi P . Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS. 1999; 13(4):501-7. DOI: 10.1097/00002030-199903110-00009. View

Munseri P, Talbot E, Mtei L, von Reyn C . Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Int J Tuberc Lung Dis. 2008; 12(9):1037-41. View

Tuller D, Bangsberg D, Senkungu J, Ware N, Emenyonu N, Weiser S . Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2009; 14(4):778-84. PMC: 2888948. DOI: 10.1007/s10461-009-9533-2. View

Briggs M, Emerson C, Modi S, Taylor N, Date A . Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature. J Acquir Immune Defic Syndr. 2015; 68 Suppl 3:S297-305. PMC: 6381831. DOI: 10.1097/QAI.0000000000000497. View

Yotebieng M, Edmonds A, Lelo P, Wenzi L, Ndjibu P, Lusiama J . High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo. AIDS. 2015; 29(15):2055-7. PMC: 4566165. DOI: 10.1097/QAD.0000000000000791. View

Chamie G, Clark T, Kabami J, Kadede K, Ssemmondo E, Steinfeld R . A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. Lancet HIV. 2016; 3(3):e111-9. PMC: 4780220. DOI: 10.1016/S2352-3018(15)00251-9. View

Namuwenge P, Mukonzo J, Kiwanuka N, Wanyenze R, Byaruhanga R, Bissell K . Loss to follow up from isoniazid preventive therapy among adults attending HIV voluntary counseling and testing sites in Uganda. Trans R Soc Trop Med Hyg. 2011; 106(2):84-9. DOI: 10.1016/j.trstmh.2011.10.015. View

Kwarisiima D, Kamya M, Owaraganise A, Mwangwa F, Byonanebye D, Ayieko J . High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. J Int AIDS Soc. 2017; 20(Suppl 4):21673. PMC: 5577724. DOI: 10.7448/IAS.20.5.21673. View

10.

Mugisha B, Bock N, Mermin J, Odeke R, Miller B, Adatu-Engwau F . Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Int J Tuberc Lung Dis. 2006; 10(7):761-7. View

11.

Grimwood A, Fatti G, Mothibi E, Malahlela M, Shea J, Eley B . Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa. J Int AIDS Soc. 2012; 15(2):17381. PMC: 3499784. DOI: 10.7448/IAS.15.2.17381. View

12.

Jacobson K, Niccolai L, Mtungwa N, Moll A, Shenoi S . "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care. 2017; 29(7):936-942. PMC: 5545149. DOI: 10.1080/09540121.2017.1283390. View

13.

Ayele H, van Mourik M, Bonten M . Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia. Int J Tuberc Lung Dis. 2016; 20(10):1342-1347. DOI: 10.5588/ijtld.15.0805. View

14.

Shayo G, Moshiro C, Aboud S, Bakari M, Mugusi F . Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania. BMC Infect Dis. 2015; 15:368. PMC: 4549887. DOI: 10.1186/s12879-015-1085-7. View

15.

Jain V, Petersen M, Liegler T, Byonanebye D, Kwarisiima D, Chamie G . Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis. Lancet HIV. 2016; 4(3):e122-e133. PMC: 5730457. DOI: 10.1016/S2352-3018(16)30220-X. View

16.

Fatti G, Meintjes G, Shea J, Eley B, Grimwood A . Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. J Acquir Immune Defic Syndr. 2012; 61(4):e50-8. DOI: 10.1097/QAI.0b013e31826a6aee. View

17.

Wilkinson D, Squire S, Garner P . Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ. 1998; 317(7159):625-9. PMC: 28654. DOI: 10.1136/bmj.317.7159.625. View